Erythrina lysistemon
Erythrina lysistemon · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Erythrina lysistemon is a distinctive plant species known for its striking floral displays and significant botanical properties. Scientific investigations into its chemical composition have identified key compounds such as Alpinumisoflavone and Abyssinone V 4'-methyl ether. Research often focuses on the medicinal potential found within the plant's leaf structures. By utilizing a crude extract of these leaves, scientists can study the bioactive elements held within the foliage. Understanding these specific chemical profiles is essential for exploring the plant's broader pharmacological applications.
- Synonyms
- Erythrina Afra Var. Mossambicensis
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Africa
- Plant Parts
- Leaf
Classification
Common Names
Erythrina lysistemon is a striking botanical specimen known by a diverse array of local and regional names. Commonly referred to as the Common Coral Tree, it is also frequently identified as the Eastern Border Luckybush. In certain areas, the plant is recognized by the name Eastern Districts Luckybean. Its cultural significance is further reflected in its Afrikaans titles, such as Gemeiner Korallenbaum. Finally, it is often called the Gewone Koraalboom, showcasing the many ways this species is categorized across different landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Erythrina lysistemon is a distinctive flowering species that is often identified through various botanical classifications. In many scientific contexts, the plant is recognized by its synonym, Erythrina afra var. mossambicensis. This taxonomic relationship highlights the complex ways in which different varieties of the genus are categorized. Understanding these naming conventions is essential for researchers studying the plant's specific regional characteristics. Consequently, recognizing both names ensures accuracy when documenting its presence in diverse ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Erythrina lysistemon is a remarkable specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further belongs to the order Fabales, which connects it to a diverse group of flowering plants. Moving down the taxonomic hierarchy, it is a distinguished member of the family Fabaceae. Ultimately, this species is identified by its specific placement within the genus Erythrina.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythrina lysistemon is a versatile species with a wide-reaching distribution across the African continent. It thrives throughout various regions, including East Tropical Africa in both Kenya and Tanzania. The plant also extends its reach into Northeast Tropical Africa, specifically within the borders of Ethiopia. Furthermore, its presence is noted in South Tropical Africa, where it can be found in Malawi. Remarkably, its range even stretches beyond the mainland to the Macaronesian islands of Madeira.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erythrina lysistemon is a self-supporting plant that takes the form of a sturdy tree. This species exhibits significant versatility in its stature, reaching a minimum height of 1.79 meters. Under optimal conditions, the tree can continue to grow until it achieves a maximum height of 10 meters. Such a range in size allows it to adapt effectively to various landscape environments.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Erythrina lysistemon is an African medicinal plant frequently utilized as a palliative for various women's health issues. Scientific analysis of this plant has identified two major constituents responsible for its biological activities: alpinumisoflavone and abyssinone V 4'-methyl ether. Research indicates that these compounds possess significant estrogenic properties, which contribute to the plant's effects on the female reproductive tract. Specifically, alpinumisoflavone has been shown to exhibit a preference for estrogen receptor alpha and can even induce apoptosis in certain lung tumor cells. Together, these isolated compounds help explain the complex pharmacological profile of Erythrina lysistemon in medicinal applications.
Conditions
Erythrina lysistemon serves as a versatile medicinal plant with significant therapeutic potential against various ailments. It is traditionally utilized to treat gut and lung infections, demonstrating broad-spectrum antimicrobial properties. Research has specifically identified its potent anti-bacterial activity, aided by compounds such as 4',5,7-trihydroxy-6-prenylisoflavone. Furthermore, the isolated compound Alpinumisoflavone helps treat lipopolysaccharide (LPS)-induced nitric oxide (NO) production by inhibiting NF-κB-dependent transcription. Finally, the plant provides targeted benefits in oncology as its derivatives can induce apoptosis in lung tumor cells.
Preparations
Erythrina lysistemon is prepared as a crude extract to investigate its medicinal properties and estrogenic effects. This plant extract was utilized in studies involving ovariectomized female Wistar rats to evaluate its impact on the genital tract. Researchers analyzed the crude extract using classic chromatographic methods to isolate its major active constituents. Specifically, the study focused on how the compounds derived from this extract influence uterine and vaginal tissue. These investigations confirm that the preparation of the plant in crude form allows for the identification of specific estrogenic principles.
Parts used
Erythrina lysistemon is a South African plant species that has been extensively studied for its medicinal potential. Researchers have specifically examined various plant parts, including the leaves, to evaluate their biological properties. During these investigations, aqueous and ethanolic extracts were used to screen the plant for cyclooxygenase inhibiting and anti-bacterial activities. While the bark often displayed higher potency in these bioassays, the leaf extracts provided essential data regarding the species' overall chemical profile. This study highlights how different components of the plant contribute to its complex pharmacological characteristics.